Most Ditch GLP-1 Drugs for Weight Loss Within a Year
Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly higher for patients without versus with type 2 diabetes (64.8% vs 46.5%), reported Ezekiel J. Emanuel, MD, PhD, of the University of Pennsylvania in Philadelphia, and colleagues.
A randomized controlled trial demonstrated a significantly reduced incidence of type 2 diabetes among individuals with metabolic syndrome who received daily metformin with or without a Mediterranean ...
Axios Charlotte on MSN3d
Demand for GLP-1s for weight loss is surging in North Carolina, just like it is nationwideThe number of prescriptions for anti-obesity GLP-1 drugs like Wegovy and Ozempic is rising in North Carolina, just as it is ...
Led by an interest in GLP-1 weight loss drugs, more health care brands may advertise in the Super Bowl this year.
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...
For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.
American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...
Companies such as Teladoc and Omada Health have embraced GLP-1s while dangling the prospect of lowered costs to their ...
Hosted on MSN4h
Looking To Come Off GLP-1 Injectables? Try Calocurb, a Natural Appetite Suppressant, Instead!Recently, there has been a lot of buzz around GLP-1 weight loss injections. Talk of Ozempic or Wegovy has been hard to miss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback